Sunday - April 13, 2025

LOGIN  |  REGISTER
C4 Therapeutics
Assertio

CareCloud CEO Hadi Chaudhry Named Finalist for Ernst & Young's Entrepreneur Of The Year® 2023 New Jersey Award

May 11, 2023 | Last Trade: US$1.19 0.06 -4.80

SOMERSET, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that the company’s president and chief executive officer, A. Hadi Chaudhry, has been named a finalist for Ernst & Young's (EY) Entrepreneur Of The Year® 2023 New Jersey Award. This prestigious award program recognizes transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable and prosperous world for all.

For more than 20 years, CareCloud has been a trailblazer in revolutionizing the revenue cycle for medical practices, prioritizing patient care in the process. Through the leadership of Chaudhry and the rest of the company's executive team, CareCloud, headquartered in New Jersey with a global workforce, has transformed the way medical practices operate. Chaudhry's journey with the company began in 2002 as an information technology manager, and he rose through the ranks to become president in 2018 and CEO in 2021. He and his team have been the driving force behind CareCloud's growth and innovation, leading to a better healthcare industry for both providers and patients.

"I'm deeply honored to have been named a finalist for EY’s prestigious award," said Chaudhry. "My success is a direct result of the hard work and dedication of the entire CareCloud team around the globe. Their unwavering commitment to upholding our core values and delivering exceptional service to our clients has established our company as a highly successful and respected healthcare technology leader. I'm immensely proud of our team's exceptional efforts, which have positioned us to make significant contributions toward shaping the future of the healthcare industry."

EY is one of the "Big Four" accounting firms, along with Deloitte, PricewaterhouseCoopers, and KPMG. These four firms are among the largest accounting and professional services firms in the world, with significant revenue and global reach, dominating the industry.

EY’s Entrepreneur Of The Year® program is a prestigious business awards program that recognizes unstoppable entrepreneurs who deliver innovation, growth, and prosperity. The program celebrates entrepreneurs through regional and national awards programs in more than 145 cities in more than 60 countries, connecting them with insights and experiences that foster growth and strengthen entrepreneurship worldwide. The New Jersey region selected 25 finalists, including Chaudhry, after an extensive evaluation process by judges consisting of past Entrepreneur Of The Year® Award recipients, civic and community leaders. The winners of the regional awards will be announced on June 12, 2023.

To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
bkorn@carecloud.com

Investor Contact:
Asher Dewhurst
ICR Westwicke
CareCloudIR@westwicke.com

Media Inquiries:
Alexis Feinberg
ICR Westwicke
CareCloudPR@westwicke.com

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page